Johnson & Johnson Spin-off

Case Code: FINC201 Case Length: 12 Pages Period: 1996- 2021 Pub Date: 2023 Teaching Note: Available

Price: Rs.200 Organization: Johnson Corporation’s (J&J) Industry: Healthcare and Services Countries: United States Themes: M&A, Corporate Restructuring

Abstract Case Intro 1 Case Intro 2 Excerpts

Introduction

On November 12, 2021, Johnson & Johnson Corporation (J&J), a US-based healthcare conglomerate, announced that the company was going to spin-off its consumer health business. The Spin-off was expected to complete by November 2023. As per the plan, J&J was going to split its business into two separate public companies. One company would deal with drugs and medical devices carrying the brand name of J&J, whereas the other company would deal with consumer health business carrying the brands like Neutrogena, Aveeno, Tylenol, Listerine, and Band-Aid. The new company’s name was going to be Kenvue. The name was inspired by the Scotland word ‘ken’, which was related to knowledge and ‘vue’ was related to sight..

Buy this case study (Please select any one of the payment options)

Price: Rs.200 Instant Download

Price: Rs.200 Express Checkout

PayPal (5 USD)